Jimenez Juarez

Dr. Jimenez Juarez

Escuela Nacional de Ciencias Biológicas-Instituto Politécnico Nacional, Mexico City, Ciudad de México, Mexico
+1

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
Jimenez JuarezJimenez Juarez
Jimenez Juarez
WCWendy Cruz-Chávez
Wendy Cruz-Chávez
NJNayeli de Jesús-Ramírez
Nayeli de Jesús-Ramírez
GCGuadalupe Ivonne Castro-Ramírez
Guadalupe Ivonne Castro-Ramírez
IUItzel Uribe-González
Itzel Uribe-González
Blanca Estela García-PérezBlanca Estela García-Pérez
Blanca Estela García-Pérez
The appearance of drug-resistant strains of Mycobacterium tuberculosis and the dramatic increase in infection rates worldwide evidences the urgency of developing new and effective compounds for treating tuberculosis. Benzimidazoles represent one possible source of new compounds given that antimycobacterial activity has already been documented for some derivatives, such as those bearing electron-withdrawing groups. The aim of this study was to synthesize two series of benzimidazoles, di- and trisubstituted derivatives, and evaluate their antimycobacterial activity. Accordingly, 5a and 5b were synthesized from hydroxymoyl halides 3a and 3b, and nitro-substituted o-phenylenediamine 4. Compound 11 was synthesized from an aromatic nitro compound, 4-chloro-1,2-phenylenediamine 9, mixed with 3-nitrobenzaldehyde 10, and bentonite clay. Although the synthesis of 11 has already been reported, its antimycobacterial activity is herein examined for the first time. 1,2,5-trisubstituted benzimidazoles 7a, 7b, and 12 were obtained from N-alkylation of 5a, 5b, and 11. All benzimidazole derivatives were characterized by FT-IR, NMR, and HR-MS, and then screened for their in vitro antimycobacterial effect against the M. tuberculosis H37Rv strain. The N-alkylated molecules (7a, 7b, and 12) generated very limited in vitro inhibition of mycobacterial growth. The benzimidazoles (5a, 5b, and 11) showed in vitro potency against mycobacteria, reflected in minimal inhibitory concentration (MIC) values in the range of 6.25–25 μg/mL. Consequently, only the 2,5-disubstituted benzimidazoles were assessed for biological activity on mouse macrophages infected with M. tuberculosis. A good effect was found for the three compounds. The cytotoxicity assay revealed very low toxicity for all the test compounds against the macrophage cell line. According to the docking study, 2,5-disubstituted benzimidazoles exhibit high affinity for an interdomain cleft that plays a key role in the GTP-dependent polymerization of the filamentous temperature-sensitive Z (FtsZ) protein. The ability of different benzimidazoles to impede FtsZ polymerization is reportedly related to their antimycobacterial activity. On the other hand, the 1,2,5-trisubstituted benzimidazoles docked to the N-terminal of the protein, close to the GTP binding domain, and did not show strong binding energies. Overall, 5a, 5b, and 11 proved to be good candidates for in vivo testing to determine their potential for treating tuberculosis.

13 February 2015 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
VCVictor A. Cardozo
Victor A. Cardozo
RSRubén Sánchez-Obregón
Rubén Sánchez-Obregón
HSHéctor Salgado-Zamora
Héctor Salgado-Zamora
Jimenez JuarezJimenez Juarez
Jimenez Juarez